The MarketWatch News Department was not involved in the creation of this content. -- Phase 1 data for DMX-1001 (noribogaine) support advancement into Phase 2 clinical trial in AUD -- AUD affects more ...
– Respondents Cited the Influence of Their Healthcare Providers and the Positive Impact of Treatment on Their Lives – AUD is a medical condition characterized by an impaired ability to stop or control ...
– Respondents Cited the Influence of Their Healthcare Providers and the Positive Impact of Treatment on Their Lives – DUBLIN, April 30, 2025 /PRNewswire/ -- A new online survey conducted by The Harris ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback